FIELD: biotechnology, in particular virulent genes and proteins.
SUBSTANCE: peptide with Neisseria meningitidis antigen activity and polynucleotide encoding the same are used in preparation of drug for prevention or treatment of diseases and conditions associated with Neisseria or gram-positive infections. Antibodies is obtained by using disclosed peptide. Vaccines for prevention or treatment of diseases and conditions associated with Neisseria meningitides contain attenuated mutant strain of Neisseria meningitides having gene mutation, insertion or deletion which disturbs expression of certain nucleotide sequence.
EFFECT: method for prevention or treatment of Neisseria infection with increased effectiveness.
13 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
NEISSERIA MENINGITIDIS PEPTIDE FOR THERAPEUTIC AND DIAGNOSTIC APPLICATION | 2001 |
|
RU2313535C2 |
NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS OF USE THEREOF | 2013 |
|
RU2665841C2 |
NON-LIPIDISED VARIANTS OF NEISSERIA MENINGITIDIS ORF2086 ANTIGENS | 2011 |
|
RU2546873C2 |
NEISSERIA MENINGITIDIS POLYPEPTIDES | 2007 |
|
RU2450019C2 |
ANTIGENES NEISSERIA MENINGITIDIS | 1999 |
|
RU2343159C2 |
NEISSERIA ANTIGENE PEPTIDES | 2000 |
|
RU2281956C2 |
GENE AND PROTEIN OF VIRULENCE AND THEIR USING | 2000 |
|
RU2240327C2 |
NEISSERIA ANTIGENIC PEPTIDES | 2000 |
|
RU2284332C2 |
NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS FOR USING THEM | 2017 |
|
RU2739504C2 |
COMPOSITION FOR TREATMENT OR PROPHYLAXIS OF INFECTION CAUSED BY MICROORGANISM NEISSERIA | 2000 |
|
RU2244749C2 |
Authors
Dates
2005-05-20—Published
2001-05-08—Filed